Donald Trump and the GOP must seize on common-sense healthcare reforms that bring down Americans’ costs without strangling innovation.

Early recognition and mitigation of drug and device integration difficulties are critical to the success of combination ...

Because price and margin headwinds exist predominantly in small-molecule oral tablets that are easy to produce, we expect Viatris’ pipeline to focus more on complex generics—drugs that have complex ...

XtalPi and DoveTree collaborate on a groundbreaking $6 billion drug discovery partnership, merging AI technology with ...

“This project is about using AI to automate and improve the early stages of drug development, particularly antibody design,” ...

Discover how AVA brings scale and reproducibility to organ‑chip technology, enabling human‑relevant insights that accelerate ...

The program has been transitioned to a permanent pathway that is designed to support innovative tools like artificial intelligence, wearables, and biomarkers in drug development and trials.

With one year until new rules on ‘high-risk’ AI systems take effect in the EU, pharmaceutical companies using AI in the ...

India's $20-billion cosmetics market has seen new brands mushroom as rising incomes spur consumption. But that also brought a ...